- Science
- Global
New 'SMArT' platform makes gene editing in hematopoietic stem cells more efficient and safer
- June 1, 2026 at 3:07 PM
- 1 views
A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a new strategy to significantly improve the precision and safety of CRISPR-Cas9 gene editing in human blood stem cells, potentially overcoming one of the major barriers limiting broader clinical application of genome editing therapies.
Originally published at Phys.org